findmyKOL
Clinical trialNCT05810623Not, yet, recruitingPhase 3Interventional

Single-Dose Intravesical Chemotherapy After Diagnostic URS

SponsorDavid D'AndreaEnrollment394Upper Urinary Tract Urothelial CarcinomaBladder Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Medical University of Vienna

    Vienna, Austria

  • Medical University of Vienna

    Vienna, Austria

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jun 2023
Primary completion
31 Dec 2025
Completion
31 Dec 2026
Last update posted
12 Apr 2023
Registered enrollment
394
Registry id
NCT05810623

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.